LabCorp Launches Another COVID-19 Solution

North Carolina Biotech News --  Burlington-based LabCorp is offering a new home-based testing service to screen patients for COVID-19 infections before they proceed with surgeries and other important medical treatments.

The At Home COVID-19 Test Collection Service received Emergency Use Authorization from the U.S. Food and Drug Administration on July 1. LabCorp is launching the service with “select” health care providers initially and then will make it available to more health systems, hospitals, and surgical centers in coming weeks, the company announced in a news release. 

“The continuing COVID-19 crisis has forced the delay of many appointments, screenings and surgeries, putting people with serious medical conditions at increased risk,” said Brian Caveney, M.D., chief medical officer and president of LabCorp Diagnostics. “Our LabCorp At Home service is simple for doctors to order and convenient for patients to use, enabling surgeries and other important treatments to get back on track so patients can manage and improve their health.” 

To Read Full Article: 

https://www.ncbiotech.org/news/labcorp-launches-another-covid-19-solution